Ginkgo Bioworks Holdings, Inc.
Company Stats
- Market Cap
- $864.0M
- as of Sep 30, 2026
- Shares Outstanding
- 67.3M
- Free Float
- 87.1%
Income Statement
- Revenue
- $170.2M
- Operating Income
- -$315.3M
- Net Income
- -$312.8M
- EBITDA
- -$275.0M
- Revenue Growth, 3Y
- -29.1%
- FCF Margin, 3Y Avg
- -135.7%
- FCF Margin, Worst Year
- -168.3%
Cash Flow
- Free Cash Flow
- -$178.7M
- FCF Yield
- -20.7%
- Owner FCF Yield
- -30.1%
Balance Sheet
- Cash & Equivalents
- $167.2M
Returns & Capital
- SBC, 3Y Avg
- $141.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $170.2M | -$178.7M | -105.0% |
| FY2024 | $227.0M | -$382.1M | -168.3% |
| FY2023 | $251.5M | -$336.3M | -133.7% |
| FY2022 | $477.7M | -$304.5M | -63.7% |
| FY2021 | $313.8M | -$310.3M | -98.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 5, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back